FinTechFunding

Osprey Medical: Receives CE Marking approval for DyeVert Power XT

  • Osprey Medical (OSP) has received CE Marking approval for its second-generation DyeVert Power XT device
  • This approval means the product can now marketed and sold across Europe, which aligns with the company’s strategy
  • The main feature of the new device is its compatibility with automated power injectors
  • Monitoring the amount of dye used is important in reducing a patient’s risk for dye-related kidney damage
  • A recently published study by Dr Carlo Briguori found a 38 per cent dye reduction in patients who received DyeVert compared to the no-DyeVert group
  • Company shares are up 8.57 per cent and trading for 3.8 cents
Previous article
Vmoto: Raises $9.6M to speed up growth opportunities
Next article
Vection Technologies: Secures partnership to target DELL global sales force
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Firenze Raises $6M to Strengthen Lombard Lending for Mass Affluent

Funding aims to enhance lending solutions for wealth management.Highlights: Firenze has raised $6 million in funding.The investment will...
FinTech

Fundtech Strengthens Leadership at Payments Infrastructure Provider Otoma

Fundtech appoints a new management team to enhance Otoma's operations.Highlights: Fundtech has appointed a new management team at...
FinTech

Ripple Strengthens Post-Quantum Readiness for XRP Ledger by 2028

Focus on enhancing security measures against future quantum computing threats.Highlights: Ripple plans to prepare the XRP Ledger for...
FinTech

New York Suits Coinbase and Gemini Over Prediction Markets

The state targets two major crypto exchanges regarding regulatory compliance.Highlights: New York has filed lawsuits against Coinbase and...